AMCP 2026 spotlighted oncology innovation, AI, and payer strategies, with KOL insights on cost, access, and evolving managed care trends.
Abby Kim, PharmD
Advertisement
Abby Kim, PharmD, is the senior director of clinical strategy and oncology specialty solutions at Prime Therapeutics.
Articles by Abby Kim, PharmD
Experts from AMCP emphasize the importance of drug-adjacent early detection tests and screening ability to improve patient outcomes.
Abby Kim, PharmD, delves into oncology trends, biomarker testing gaps, and evolving clinical pathways shaping precision care and treatment decisions.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Hybrid, Outpatient, Network-Based: Bispecific Programs Take Shape Differently
2
Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD
3
Defunding Co-Payment Assistance Disrupted nAMD Care
4
5 Ongoing Clinical Trials in Myeloproliferative Neoplasms
5